Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth.

Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC 20057, USA.
Molecular and Cellular Biology (Impact Factor: 5.04). 01/2004; 23(23):8563-75. DOI: 10.1128/MCB.23.23.8563-8575.2003
Source: PubMed

ABSTRACT Modification by acetylation occurs at epsilon-amino lysine residues of histones and transcription factors. Unlike phosphorylation, a direct link between transcription factor acetylation and cellular growth or apoptosis has not been established. We show that the nuclear androgen receptor (AR), a DNA-binding transcriptional regulator, is acetylated in vivo. The acetylation of the AR is induced by ligand dihydrotestosterone and by histone deacetylase (HDAC) inhibitors in living cells. Direct AR acetylation augmented p300 binding in vitro. Constructs mimicking neutral polar substitution acetylation (AR(K630Q), AR(K630T)) enhanced p300 binding and reduced N-CoR/HDAC/Smad3 corepressor binding, whereas charged residue substitution (AR(K630R)) reduced p300 binding and enhanced corepressor binding. The AR acetylation mimics promoted cell survival and growth of prostate cancer cells in soft agar and in nude mice and augmented transcription of a subset of growth control target gene promoters. Thus, transcription factor acetylation regulates coactivator/corepressor complex binding, altering expression of specific growth control genes to promote aberrant cellular growth in vivo.


Available from: Maria Laura Avantaggiati, Feb 22, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Prostatic intraepithelial neoplasia is a precursor to prostate cancer. Herein, deletion of the NAD(+)-dependent histone deacetylase Sirt1 induced histological features of prostatic intraepithelial neoplasia at 7 months of age; these features were associated with increased cell proliferation and enhanced mitophagy. In human prostate cancer, lower Sirt1 expression in the luminal epithelium was associated with poor prognosis. Genetic deletion of Sirt1 increased mitochondrial superoxide dismutase 2 (Sod2) acetylation of lysine residue 68, thereby enhancing reactive oxygen species (ROS) production and reducing SOD2 activity. The PARK2 gene, which has several features of a tumor suppressor, encodes an E3 ubiquitin ligase that participates in removal of damaged mitochondria via mitophagy. Increased ROS in Sirt1(-/-) cells enhanced the recruitment of Park2 to the mitochondria, inducing mitophagy. Sirt1 restoration inhibited PARK2 translocation and ROS production requiring the Sirt1 catalytic domain. Thus, the NAD(+)-dependent inhibition of SOD2 activity and ROS by SIRT1 provides a gatekeeper function to reduce PARK2-mediated mitophagy and aberrant cell survival. Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
    American Journal Of Pathology 01/2015; 185(1):266-79. DOI:10.1016/j.ajpath.2014.09.014 · 4.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Psychiatric disease is believed to result from a combination of genetic vulnerability and environmental influence. At the crux are epigenetic modifications, which mediate the influence of environment on the genome. Twin and genome-wide association studies demonstrate a wide range of heritabilities across psychiatric disorders, while epidemiological and animal models implicate distinct developmental windows where environmental factors may interact with genetic vulnerability to confer risk. Certain developmental periods appear to be more prone to these influences including during gestation, in the early postnatal period, and during periods of major hormonal rearrangement. Here we review the role of environmental factors capable of epigenetic reprogramming during these periods and present evidence for the link between these modifications and disease. The cross tissue relevance of environmentally induced epigenetic change and its utility for identifying peripheral biomarkers is discussed.
    Neuroscience Research 08/2014; DOI:10.1016/j.neures.2014.08.003 · 2.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hey bHLH transcription factors are direct targets of canonical Notch signaling. The three mammalian Hey proteins are closely related to Hes proteins and they primarily repress target genes by either directly binding to core promoters or by inhibiting other transcriptional activators. Individual candidate gene approaches and systematic screens identified a number of Hey target genes, which often encode other transcription factors involved in various developmental processes. Here, we review data on interaction partners and target genes and conclude with a model for Hey target gene regulation. Furthermore, we discuss how expression of Hey proteins affects processes like cell fate decisions and differentiation, e.g., in cardiovascular, skeletal, and neural development or oncogenesis and how this relates to the observed developmental defects and phenotypes observed in various knockout mice.
    Current Topics in Developmental Biology 01/2014; 110C:285-315. DOI:10.1016/B978-0-12-405943-6.00008-7 · 4.21 Impact Factor